Enhabit, Inc. (EHAB)
NYSE: EHAB · IEX Real-Time Price · USD
8.76
+0.01 (0.11%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Company Description

Enhabit, Inc. provides home health and hospice services in the United States.

Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families.

The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022.

Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.

Enhabit, Inc.
Enhabit logo
Country United States
Founded 2014
Industry Medical Care Facilities
Sector Healthcare
Employees 10,800
CEO Ms. Barbara Ann Jacobsmeyer B.S., M.A., P.T.

Contact Details

Address:
6688 N. Central Expressway, Suite 1300
Dallas, Texas 75206
United States
Phone (469) 621-6419
Website ehab.com

Stock Details

Ticker Symbol EHAB
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001803737
CUSIP Number 29332G102
ISIN Number US29332G1022
Employer ID 47-2409192
SIC Code 8082

Key Executives

Name Position
Barbara Ann Jacobsmeyer B.S., M.A., P.T. President, Chief Executive Officer and Director
Crissy Buchanan Carlisle Executive Vice President and Chief Financial Officer
Julie Diane Jolley B.S.N., R.N. Executive Vice President of Operations
Tanya R. Marion Chief Human Resources Officer
Jeanne Kalvaitis B.S.N., R.N. Executive Vice President of Hospice Operations
Dylan C. Black General Counsel and Secretary
Ronald L. Langham Jr., M.B.A., P.T. Executive Vice President of Clinical Excellence and Strategy

Latest SEC Filings

Date Type Title
Jul 1, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Jul 1, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Jun 27, 2024 DFAN14A Filing
Jun 26, 2024 DFAN14A Filing
Jun 24, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Jun 18, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Jun 17, 2024 DFAN14A Filing
Jun 17, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Jun 12, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Jun 11, 2024 DFAN14A Filing